Strides allots to Shasun shareholders

Strides Arcolab has informed the BSE that it has allotted 2.10 crore shares of ₹10 each to the shareholders of erstwhile Shasun Pharmaceuticals, in the ratio of five shares of ₹10 each of Strides Arcolab for every 16 shares of Shasun. The allotment was decided at the meeting of the allotment committee of the Board of Directors on November 20, . Consequent to this allotment, the paid-up equity share capital of the company has increased to ₹80.642 crore from ₹59.625 crore. S Abhaya Kumar, CEO of erstwhile Shasun, has been appointed Executive Director of the company from November 19.